These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 913695)

  • 21. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia.
    Ukai M; Inoue I; Itatsu T
    Endocrinology; 1977 May; 100(5):1284-6. PubMed ID: 849724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
    Meister R; Berger I; Schwille PO; Gebhardt C
    Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
    Valverde I; Dobbs R; Unger RH
    Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phentolamine prevents the somatostatin-mediated inhibition of pancreatic glucagon secretion.
    Smith PH; Woods SC; Ensinck JW; Porte D
    Metabolism; 1977 Aug; 26(8):841-5. PubMed ID: 195179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
    Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
    Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin and glucagon breakthrough of somatostatin suppression: importance of portal vein hormone measurements.
    Polonsky K; Jaspan J; Pugh W; Dhorajiwala J; Abraham M; Blix P; Moossa AR
    Diabetes; 1981 Aug; 30(8):664-9. PubMed ID: 6114006
    [No Abstract]   [Full Text] [Related]  

  • 31. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of glucagon-insulin interactions in control of glucose turnover and its significance in diabetes.
    Vranic M; Ross G; Doi K; Lickley L
    Metabolism; 1976 Nov; 25(11 Suppl 1):1375-80. PubMed ID: 790086
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental studies on pancreatic endocrine function of dogs after pancreatic duct ligation (author's transl)].
    Nishiwaki H; Sakazaki S; Shin K; Satake K; Umeyama K
    Nihon Shokakibyo Gakkai Zasshi; 1979 Apr; 76(4):934-41. PubMed ID: 376908
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.
    Werner PL; Palmer JP
    Diabetes; 1978 Oct; 27(10):1005-12. PubMed ID: 700256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.
    Sherwin R; Wahren J; Felig P
    Metabolism; 1976 Nov; 25(11 Suppl 1):1381-3. PubMed ID: 979638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extrapancreatic glucagon in the dog (author's transl)].
    Lefebvre J; Luyckx AS
    Ann Endocrinol (Paris); 1980; 41(3):241-2. PubMed ID: 7416711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of extrapancreatic glucagon to glycemic changes under chronic insulin deficiency in dogs.
    Kobayashi T; Nihei J; Ohneda A
    Tohoku J Exp Med; 1983 Dec; 141(4):481-8. PubMed ID: 6367144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.